Proceedings of the International Scientific Conference “Cancer, Work & Employment” Paris, November 21 and 22, 2022
Compte rendu de la conférence scientifique internationale « Cancer, Travail et Emploi » Paris, 21 et 22 novembre 2022
Abstract
This paper is an overview of the International Scientific Conference on “Cancer, Work & Employment” that was held in Paris on November 21 and 22, 2022, and organized by the French National Cancer Institute (INCa). The conference was structured around four keynote presentations and two roundtables, with renowned international speakers. The focus of this conference was to discuss the challenges of return or access to work and job retention when facing cancer, from interdisciplinary perspectives (e.g., psychology, sociology, economics). Speakers analyzed return-to-work (RTW) determinants for cancer patients, with a particular focus on specific forms of cancer, working conditions (e.g., self-employment, adaptations at work when returning), and the influence of differences in social welfare systems. Current interventions to support RTW were analyzed, from the patient’s point of view and in terms of improving healthcare professionals’ practices. Prospects for future research in the field were also discussed (e.g., focus on underrepresented populations, considering the influence of longer treatments, incorporating changes in career paths). Finally, the broad spectrum of disciplines and the diversity in involved countries offered a rare opportunity to exchange ideas and helped initiate collaboration between participants.
References
2. Torp S, Nielsen RA, Gudbergsson SB, et al (2012) Sick leave patterns among 5-year cancer survivors: a registry-based retrospective cohort study. J Cancer Surviv 6:315–23
3. Cocchiara RA, Sciarra I, D’Egidio V, et al (2018) Returning to work after breast cancer: a systematic review of reviews. Work 61:463–76
4. Timperi AW, Ergas IJ, Rehkopf DH, et al (2013) Employment status and quality of life in recently diagnosed breast cancer survivors. Psycho-Oncology 22:1411–20
5. INCa & Inserm (2018) VICAN 5 Survey “Life five years after a diagnosis of cancer.”
6. Lamore K, Dubois T, Rothe U, et al (2019) Return to work interventions for cancer survivors: a systematic review and a methodological critique. Int J Environ Res Public Health 16:1343
7. Porro B, Campone M, Moreau P, et al (2022) Supporting the return to work of breast cancer survivors: from a theoretical to a clinical perspective. Int J Environ Res Public Health 19:5124
8. Loisel P, Buchbinder R, Hazard R, et al (2005) Prevention of work disability due to musculoskeletal disorders: the challenge of implementing evidence. J Occup Rehabil 15:507–24
9. INCa (2020) Le Club des entreprises « Cancer et emploi ». https://www.e-cancer.fr/Institut-national-du-cancer/Cancer-etemploi/Le-Club-et-l-accompagnement-des-signataires/Le-Clubdes-entreprises
10. Tamminga SJ, de Wind A, Greidanus MA, et al (2022) Prognostic factors for return to work in breast cancer survivors. Cochrane Database Syst Rev 2022:CD015124. https://doi.org/10.1002/14651858. CD015124
11. Fassier JB, Lamort-Bouché M, Sarnin P, et al (2016) The intervention mapping protocol: a structured process to develop, implement and evaluate health promotion programs. Rev Epidemiol Sante Publique 64:33–44. https://doi.org/10.1016/j.respe.2015.10.002
12. Lamort-Bouché M, Sarnin P, Kok G, et al (2018) Interventions developed with the intervention mapping protocol in the field of cancer: a systematic review. Psycho-Oncology 27:1138–49
13. Fassier JB, Sarnin P, Rouat S, et al (2019) Interventions developed with the intervention mapping protocol in work disability prevention: a systematic review of the literature. J Occup Rehabil 29:11–24
14. Dupoyet C, Guittard L, Rouat S, et al (2020) Retour à l’emploiaprès cancer du sein: apports de la recherche collaborative ensanté au travail et d’une charte de partenariat entre acteurs concernés. Arch Mal Prof Environ 81:797–810
15. Fassier JB, Lamort-Bouché M, Broc G, et al (2018) Developing a return to work intervention for breast cancer survivors with the intervention mapping protocol: challenges and opportunities of the needs assessment. Front Public Health 6:35
16. Munir F, Kalawsky K, Wallis D, et al (2013) Using intervention mapping to develop a work-related guidance tool for those affected by cancer. BMC Public Health 13:6
17. Skivington K, Craig P, Moore L, et al (2021) Introduction to the complex intervention concept and the research perspectives. Eur J Public Health 31:ckab164.803
18. Bradley CJ, Neumark D, Bednarek HL, et al (2005) Short-term effects of breast cancer on labor market attachment: results from a longitudinal study. J Health Econ 24:137–160
19. Cox-Martin E, Anderson-Mellies A, Borges V, et al (2020) Chronic pain, health-related quality of life, and employment in working-age cancer survivors. J Cancer Surviv 14:179–187
20. Neumark D, Bradley CJ, Henry M, et al (2015) Work continuation while treated for breast cancer: the role of workplace accommodations. Ind Labor Relat Rev 68:916–54
21. de Rijk A, Carrasco-Negüe K, Houkes I (2022) The cross-country comparison model for labor participation (CCC model for LP) of persons with chronic diseases. J Occup Rehabil 32:225–40
22. Ravinskaya M, Verbeek JH, Langendam MW, et al (2022) Preferred methods of measuring work participation: an international survey among Trialists and Cochrane systematic reviewers. J Occup Rehabil 32:620–8
23. Silvaggi F, Eigenmann M, Scaratti C, et al (2020) Employment and chronic diseases: suggested actions for the implementation of inclusive policies for the participation of people with chronic diseases in the labour market. Int J Environ Res Public Health 17:820
24. Braspenning I, Tamminga S, Frings-Dresen MHW, et al (2018) Rehabilitation and return to work after cancer—instruments and practices [Report]. Loughborough University. https://doi.org/10.2802/170868
25. ECL—Patient Support Working Group (2020) How to manage cancer at work (ECL). ECL
26. Psycho-Oncol. (2023) 17:11-1726. de Heus E, Duijts SFA, van der Zwan JM, et al (2022) The gap between rare and common cancers still exists: results from a population-based study in the Netherlands. Eur J Cancer 167:103–11
27. Olischläger DL, den Boer LXY, de Heus E, et al (2022) Rare cancer and return to work: experiences and needs of patients and (health care) professionals. Disabil Rehabil 1–12. doi: 10.1080/09638288.2022.2099589 (Online ahead of print)
28. de Heus E, van der Zwan JM, Husson O, et al (2021) Unmet supportive care needs of patients with rare cancer: a systematic review. Eur J Cancer Care 30:e13502
29. Bouhnik AD, Bendiane MK, Cortaredona S, et al (2015) The labour market, psychosocial outcomes and health conditions in cancer survivors: protocol for a nationwide longitudinal survey 2 and 5 years after cancer diagnosis (the VICAN survey). BMJ Open 5:e005971
30. Alleaume C, Paraponaris A, Bendiane MK, et al (2020) The positive effect of workplace accommodations on the continued employment of cancer survivors five years after diagnosis. Support Care Cancer 28:4435–43
31. Popa AE, Bejenaru A, Mitrea EC, et al (2022) Return to work after chronic disease: a theoretical framework for understanding the worker-employer dynamic. Chronic Illn 17423953221117852. doi: 10.1177/17423953221117852 (Online ahead of print)
32. Popa AE, Popa RI (2020) Working as a cancer survivor in Romania: an overview of the statutory policies for return to work. Disabil Rehabil 42:2679–86
33. Torp S, Paraponaris A, Van Hoof E, et al (2019) Work-related outcomes in self-employed cancer survivors: a European multi country study. J Occup Rehabil 29:361–74
34. Torp S, Brusletto B, Withbro TB, et al (2020) Work experiences during and after treatment among self-employed people with cancer. J Occup Rehabil 30:49–58
35. Roquelaure Y (2021) New forms of work in the digital era: implications for psychosocial risks and musculoskeletal disorders. European Agency for Safety and Health at Work. https://osha.europa.eu/fr/publications/digitalisation-work-psychosocial-riskfactors-and-work-related-musculoskeletal
Copyright (c) 2023 The author(s).
This work is licensed under a Creative Commons Attribution 4.0 International License.